2004 NEWS RELEASES
[Other Years]

December 20, 2004

• Protecting Competition, FTC Clears Genzyme Corp.’s $1 Billion Acquisition of Ilex Oncology, Inc.
  Divestitures Required in the U.S. Market for Solid Organ Transplant Acute Therapy Drugs

November 16, 2004

• Administrative Law Judge Upholds FTC Complaint Against North Texas Specialty Physicians
  Rules Doctors’ Group Engaged in “Contract, Combination, or Conspiracy to Fix Prices”

October 5, 2004

• For Your Information:
  Announced Actions for October 5, 2004

September 28, 2004

• New Mexico PHO, Physician Group, and Their Agent Settle FTC Price-Fixing Charges

September 24, 2004

• For Your Information:
  Announced Actions for September 24, 2004

August 12, 2004

• Generic Drug Marketers Settle FTC Charges
  Complaint Charges Unlawful Agreement Not to Compete Drove Up Prices for Over-the-Counter Children’s Ibuprofen; Companies to Give-Up Illegal Profit

August 11, 2004

• Piedmont Health Alliance Settles FTC Price-fixing Charges

August 9, 2004

• With Conditions, FTC Allows Cephalon’s Purchase of CIMA, Protecting Competition for Breakthrough Cancer Pain Drugs
  Consent Order Requires Cephalon to Grant Third-Party License to Sell Generic Actiq in U.S.

August 6, 2004

• For Your Information:
  Announced Action for August 6, 2004

July 30, 2004

• FTC Denies State Dental Board’s Dismissal Motion on State Action Grounds
  Commission Remands Case to Administrative Law Judge

July 28, 2004

• Resolving Anticompetitive Concerns, FTC Clears Sanofi-Synthélabo’s Acquisition of Aventis
  Sanofi Required to Divest Arixtra®, Campto® Studies, and Royalty Rights to Sepracor’s Estorra®

July 23, 2004

• FTC and DOJ Issue Report on Competition and Health Care
  Report Reviews the Role of Competition, Provides Recommendations to Improve the Balance Between Competition and Regulation in Health Care

July 16, 2004

• For Your Information:
  Announced Action for July 16, 2004

June 7, 2004

• New Mexico Physicians' Group Agrees to Settle FTC Price-Fixing Charges

May 25, 2004

• For Your Information:
  Announced Actions for May 25, 2004
  The Commission has authorized the filing of a joint amicus brief with the Department of Justice in McMahon v. Advanced Title Services Company of West Virginia, a case before the West Virginia Supreme Court of Appeals.The Commission has advised Bristol-Myers Squibb (BMS) that its proposed settlement with Teva Pharmaceuticals USA, Inc., does not raise issues under Section 5 of the Federal Trade Commission Act.

May 11, 2004

• For Your Information:
  Announced Action for May 11, 2004
  By a vote of 5-0, the Commission has approved a final consent order and authorized the staff to send letters to the commentors of record in the matter concerning California Pacific Medical Group, Inc, d/b/a Brown & Toland Medical Group The Commission has published transcripts of the three-day joint FTC/DOJ Workshop on Merger Enforcement held in Washington, DC, on February 17-19, 2004.

April 2, 2004

• For Your Information
  Announced Actions for April 2, 2004
  The Commission has filed in Federal court its complaint, stipulation, and agreed-to judgment against RHI AG (RHI) to resolve charges that RHI violated various provisions of an FTC order issued in 2001. The Commission has authorized the staff to seek leave to file an amended complaint in the matter currently pending against A. Glenn Braswell, et al. The Commission has authorized the staff to file an amicus curiae brief in Teva Pharmaceuticals USA v. Pfizer, Inc., Case No. 04-1186.

February 11, 2004

• FTC Closes Its Investigation Into Caremark Rx’s Proposed Acquisition of Advance PCS
  Transaction Involves Two U.S. Providers of Prescription Benefit Management Services

February 10, 2004

• FTC Challenges Hospital Merger That Allegedly Led to Anticompetitive Price Increases

February 9, 2004

• San Francisco’s Brown & Toland Medical Group Settles FTC Price Fixing Charges

January 13, 2004

• FTC Closes its Investigation of Genzyme Corporation's 2001 Acquisition of Novazyme Pharmaceuticals, Inc.
  Separate Statements Issued by Chairman Muris, Commissioners Thompson and Jones Harbour
  

• For Your Information
  Announced Actions for January 13, 2004
  The Commission has approved a petition from Wright Medical Technology, Inc. (Wright) to reopen and modify a 1994 consent order that arose from Wright’s cash tender offer for all shares of common stock and outstanding convertible preferred stock of Orthomet, Inc.; Tthe Commission has approved a final consent order and letter to the commenter of record in the matter concerning Memorial Hermann Health Network Providers.; The Commission has approved the publication of a Federal Register notice concerning the FTC’s regulatory review schedule.

January 9, 2004

• For Your Information
  Announced Actions for January 9, 2004
  Staff of the Commission’s Bureau of Competition has issued an advisory opinion at the request of Dunlap Memorial Hospital (Dunlap) in Orrville, Ohio, addressing whether Dunlap’s provision of pharmaceuticals to the Viola Startzman Free Clinic (Free Clinic) would fall within the scope of the Non-Profit Institutions Act (NPIA). Following a public comment period, the Commission has approved a modified final consent order in the matter concerning DSM N.V./Roche Holding AG and Koninklijke DSM N.V., et al.

Last Updated: Friday, October 6, 2006